Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections
This study aims to determine whether relative miR-122 levels in peripheral blood are correlated with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) virus infection and viral replication to determine whether miR-122 can be a new marker for liver injury. MicroRNA (miRNA) was extracted from th...
Gespeichert in:
Veröffentlicht in: | Cytokine (Philadelphia, Pa.) Pa.), 2020-07, Vol.131, p.155076-155076, Article 155076 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 155076 |
---|---|
container_issue | |
container_start_page | 155076 |
container_title | Cytokine (Philadelphia, Pa.) |
container_volume | 131 |
creator | Ma, Zhen-Hua Sun, Cheng-Xue Shi, Hong Fan, Jian-Hua Song, Yu-Guo Cong, Pei-Jun Kong, Xiang-Min Hao, Da-Lin |
description | This study aims to determine whether relative miR-122 levels in peripheral blood are correlated with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) virus infection and viral replication to determine whether miR-122 can be a new marker for liver injury.
MicroRNA (miRNA) was extracted from the peripheral blood of 20 CHB patients, 20 CHC patients, and 20 healthy controls. The levels of miR-122 were determined using fluorescence real-time reverse transcription PCR. Then, the associations of miR-122 with CHB and CHC were analyzed, and its correlation with other markers of liver function and viral replication were determined.
The expression level of miR-122 in patients with CHB was significantly higher when compared to subjects in the control group (P = 0.007) or CHC patients (P = 0.005). Furthermore, the miR-122 level in patients with CHC was somewhat higher when compared to healthy controls (66% higher), but the difference was not statistically significant (P = 0.229). MiR-122 levels were significantly correlated with ALT (correlation coefficient [R] = 0.7, P |
doi_str_mv | 10.1016/j.cyto.2020.155076 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2390149521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043466620300922</els_id><sourcerecordid>2390149521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e82a721827d43f2717656510c0a74141aef98f147e16498b58eeb0979e0203373</originalsourceid><addsrcrecordid>eNp9kEtr3DAUhUVpyKv5A10ELbvxRA9bsiCbdpoXDCSEdi1k-YrRYFtTSZMy_74yTrvs6l4u55zL-RD6TMmKEipudit7zGHFCCuHpiFSfEDnlChREcL4x3mveVULIc7QRUo7QojiUp6iM85YqwRT5yh9hww2-zDh4PDoXyvKGO6O2A2HECFZmCzgCGaosh8Bv6xfsZ9wN4TQYxfDiPcme5hywr993mK7jWHyFm9hvmef8Ddsph6vi8stj9IndOLMkODqfV6in_d3P9aP1eb54Wn9dVNZ3ohcQcuMZLRlsq-5Y5JK0YiGEkuMrGlNDTjVOlpLoKJWbde0AB1RUkEBwrnkl-jLkruP4dcBUtajL4WGwUwQDkkzrgitVcNokbJFamNIKYLT--hHE4-aEj3D1js9w9YzbL3ALqbr9_xDN0L_z_KXbhHcLgIoLd88RJ2sn4H2PhYWug_-f_l_APnkjno</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390149521</pqid></control><display><type>article</type><title>Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Ma, Zhen-Hua ; Sun, Cheng-Xue ; Shi, Hong ; Fan, Jian-Hua ; Song, Yu-Guo ; Cong, Pei-Jun ; Kong, Xiang-Min ; Hao, Da-Lin</creator><creatorcontrib>Ma, Zhen-Hua ; Sun, Cheng-Xue ; Shi, Hong ; Fan, Jian-Hua ; Song, Yu-Guo ; Cong, Pei-Jun ; Kong, Xiang-Min ; Hao, Da-Lin</creatorcontrib><description>This study aims to determine whether relative miR-122 levels in peripheral blood are correlated with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) virus infection and viral replication to determine whether miR-122 can be a new marker for liver injury.
MicroRNA (miRNA) was extracted from the peripheral blood of 20 CHB patients, 20 CHC patients, and 20 healthy controls. The levels of miR-122 were determined using fluorescence real-time reverse transcription PCR. Then, the associations of miR-122 with CHB and CHC were analyzed, and its correlation with other markers of liver function and viral replication were determined.
The expression level of miR-122 in patients with CHB was significantly higher when compared to subjects in the control group (P = 0.007) or CHC patients (P = 0.005). Furthermore, the miR-122 level in patients with CHC was somewhat higher when compared to healthy controls (66% higher), but the difference was not statistically significant (P = 0.229). MiR-122 levels were significantly correlated with ALT (correlation coefficient [R] = 0.7, P < 0.001), AST (R = 0.71, P < 0.001), and HBV NA (R = 0.9, P < 0.001). The regression analysis indicated that the AUC of miR-122 levels in the diagnosis of CHB was 0.87, with a sensitivity of 0.8 and a specificity of 0.8.
MiR-122 can be used to distinguish healthy persons and patients with CHB infection with high sensitivity and specificity. These present findings presented that the complex and context-specific associations of miR-122 with liver diseases, suggesting that this may be a promising marker for liver injury.</description><identifier>ISSN: 1043-4666</identifier><identifier>EISSN: 1096-0023</identifier><identifier>DOI: 10.1016/j.cyto.2020.155076</identifier><identifier>PMID: 32289629</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chronic hepatitis B ; Chronic hepatitis C ; Fluorescence real-time PCR ; miR-122</subject><ispartof>Cytokine (Philadelphia, Pa.), 2020-07, Vol.131, p.155076-155076, Article 155076</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e82a721827d43f2717656510c0a74141aef98f147e16498b58eeb0979e0203373</citedby><cites>FETCH-LOGICAL-c356t-e82a721827d43f2717656510c0a74141aef98f147e16498b58eeb0979e0203373</cites><orcidid>0000-0003-0484-0421</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cyto.2020.155076$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32289629$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ma, Zhen-Hua</creatorcontrib><creatorcontrib>Sun, Cheng-Xue</creatorcontrib><creatorcontrib>Shi, Hong</creatorcontrib><creatorcontrib>Fan, Jian-Hua</creatorcontrib><creatorcontrib>Song, Yu-Guo</creatorcontrib><creatorcontrib>Cong, Pei-Jun</creatorcontrib><creatorcontrib>Kong, Xiang-Min</creatorcontrib><creatorcontrib>Hao, Da-Lin</creatorcontrib><title>Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections</title><title>Cytokine (Philadelphia, Pa.)</title><addtitle>Cytokine</addtitle><description>This study aims to determine whether relative miR-122 levels in peripheral blood are correlated with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) virus infection and viral replication to determine whether miR-122 can be a new marker for liver injury.
MicroRNA (miRNA) was extracted from the peripheral blood of 20 CHB patients, 20 CHC patients, and 20 healthy controls. The levels of miR-122 were determined using fluorescence real-time reverse transcription PCR. Then, the associations of miR-122 with CHB and CHC were analyzed, and its correlation with other markers of liver function and viral replication were determined.
The expression level of miR-122 in patients with CHB was significantly higher when compared to subjects in the control group (P = 0.007) or CHC patients (P = 0.005). Furthermore, the miR-122 level in patients with CHC was somewhat higher when compared to healthy controls (66% higher), but the difference was not statistically significant (P = 0.229). MiR-122 levels were significantly correlated with ALT (correlation coefficient [R] = 0.7, P < 0.001), AST (R = 0.71, P < 0.001), and HBV NA (R = 0.9, P < 0.001). The regression analysis indicated that the AUC of miR-122 levels in the diagnosis of CHB was 0.87, with a sensitivity of 0.8 and a specificity of 0.8.
MiR-122 can be used to distinguish healthy persons and patients with CHB infection with high sensitivity and specificity. These present findings presented that the complex and context-specific associations of miR-122 with liver diseases, suggesting that this may be a promising marker for liver injury.</description><subject>Chronic hepatitis B</subject><subject>Chronic hepatitis C</subject><subject>Fluorescence real-time PCR</subject><subject>miR-122</subject><issn>1043-4666</issn><issn>1096-0023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtr3DAUhUVpyKv5A10ELbvxRA9bsiCbdpoXDCSEdi1k-YrRYFtTSZMy_74yTrvs6l4u55zL-RD6TMmKEipudit7zGHFCCuHpiFSfEDnlChREcL4x3mveVULIc7QRUo7QojiUp6iM85YqwRT5yh9hww2-zDh4PDoXyvKGO6O2A2HECFZmCzgCGaosh8Bv6xfsZ9wN4TQYxfDiPcme5hywr993mK7jWHyFm9hvmef8Ddsph6vi8stj9IndOLMkODqfV6in_d3P9aP1eb54Wn9dVNZ3ohcQcuMZLRlsq-5Y5JK0YiGEkuMrGlNDTjVOlpLoKJWbde0AB1RUkEBwrnkl-jLkruP4dcBUtajL4WGwUwQDkkzrgitVcNokbJFamNIKYLT--hHE4-aEj3D1js9w9YzbL3ALqbr9_xDN0L_z_KXbhHcLgIoLd88RJ2sn4H2PhYWug_-f_l_APnkjno</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Ma, Zhen-Hua</creator><creator>Sun, Cheng-Xue</creator><creator>Shi, Hong</creator><creator>Fan, Jian-Hua</creator><creator>Song, Yu-Guo</creator><creator>Cong, Pei-Jun</creator><creator>Kong, Xiang-Min</creator><creator>Hao, Da-Lin</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0484-0421</orcidid></search><sort><creationdate>202007</creationdate><title>Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections</title><author>Ma, Zhen-Hua ; Sun, Cheng-Xue ; Shi, Hong ; Fan, Jian-Hua ; Song, Yu-Guo ; Cong, Pei-Jun ; Kong, Xiang-Min ; Hao, Da-Lin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e82a721827d43f2717656510c0a74141aef98f147e16498b58eeb0979e0203373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Chronic hepatitis B</topic><topic>Chronic hepatitis C</topic><topic>Fluorescence real-time PCR</topic><topic>miR-122</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ma, Zhen-Hua</creatorcontrib><creatorcontrib>Sun, Cheng-Xue</creatorcontrib><creatorcontrib>Shi, Hong</creatorcontrib><creatorcontrib>Fan, Jian-Hua</creatorcontrib><creatorcontrib>Song, Yu-Guo</creatorcontrib><creatorcontrib>Cong, Pei-Jun</creatorcontrib><creatorcontrib>Kong, Xiang-Min</creatorcontrib><creatorcontrib>Hao, Da-Lin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytokine (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ma, Zhen-Hua</au><au>Sun, Cheng-Xue</au><au>Shi, Hong</au><au>Fan, Jian-Hua</au><au>Song, Yu-Guo</au><au>Cong, Pei-Jun</au><au>Kong, Xiang-Min</au><au>Hao, Da-Lin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections</atitle><jtitle>Cytokine (Philadelphia, Pa.)</jtitle><addtitle>Cytokine</addtitle><date>2020-07</date><risdate>2020</risdate><volume>131</volume><spage>155076</spage><epage>155076</epage><pages>155076-155076</pages><artnum>155076</artnum><issn>1043-4666</issn><eissn>1096-0023</eissn><abstract>This study aims to determine whether relative miR-122 levels in peripheral blood are correlated with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) virus infection and viral replication to determine whether miR-122 can be a new marker for liver injury.
MicroRNA (miRNA) was extracted from the peripheral blood of 20 CHB patients, 20 CHC patients, and 20 healthy controls. The levels of miR-122 were determined using fluorescence real-time reverse transcription PCR. Then, the associations of miR-122 with CHB and CHC were analyzed, and its correlation with other markers of liver function and viral replication were determined.
The expression level of miR-122 in patients with CHB was significantly higher when compared to subjects in the control group (P = 0.007) or CHC patients (P = 0.005). Furthermore, the miR-122 level in patients with CHC was somewhat higher when compared to healthy controls (66% higher), but the difference was not statistically significant (P = 0.229). MiR-122 levels were significantly correlated with ALT (correlation coefficient [R] = 0.7, P < 0.001), AST (R = 0.71, P < 0.001), and HBV NA (R = 0.9, P < 0.001). The regression analysis indicated that the AUC of miR-122 levels in the diagnosis of CHB was 0.87, with a sensitivity of 0.8 and a specificity of 0.8.
MiR-122 can be used to distinguish healthy persons and patients with CHB infection with high sensitivity and specificity. These present findings presented that the complex and context-specific associations of miR-122 with liver diseases, suggesting that this may be a promising marker for liver injury.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32289629</pmid><doi>10.1016/j.cyto.2020.155076</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0484-0421</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-4666 |
ispartof | Cytokine (Philadelphia, Pa.), 2020-07, Vol.131, p.155076-155076, Article 155076 |
issn | 1043-4666 1096-0023 |
language | eng |
recordid | cdi_proquest_miscellaneous_2390149521 |
source | ScienceDirect Journals (5 years ago - present) |
subjects | Chronic hepatitis B Chronic hepatitis C Fluorescence real-time PCR miR-122 |
title | Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20miR-122%20by%20fluorescence%20real-time%20PCR%20in%20blood%20from%20patients%20with%20chronic%20hepatitis%20B%20and%20C%20infections&rft.jtitle=Cytokine%20(Philadelphia,%20Pa.)&rft.au=Ma,%20Zhen-Hua&rft.date=2020-07&rft.volume=131&rft.spage=155076&rft.epage=155076&rft.pages=155076-155076&rft.artnum=155076&rft.issn=1043-4666&rft.eissn=1096-0023&rft_id=info:doi/10.1016/j.cyto.2020.155076&rft_dat=%3Cproquest_cross%3E2390149521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2390149521&rft_id=info:pmid/32289629&rft_els_id=S1043466620300922&rfr_iscdi=true |